What would happen if DNA get mutated?

DNA mutations can lead to a variety of effects, depending on where in the DNA sequence the mutation occurs and what type of mutation it is. Mutations in different genes or parts of genes can have mild to severe consequences on health and development. Some examples of what could happen if DNA gets mutated include:

Cellular Effects

Mutations in DNA sequences that code for vital cellular proteins or enzymes could impair the normal function of cells. For example, a mutation could alter an enzyme active site so that the enzyme can no longer bind its substrate or perform catalysis. This could disrupt major cellular pathways and prevent cells from carrying out essential processes like metabolism, cell division, or DNA replication and repair.

Likewise, a mutation affecting a structural protein like actin or myosin could affect cell shape, migration, division, or communication with other cells. Tumor suppressor genes and oncogenes are also common targets of DNA mutation – changes in these genes disturb the cell cycle and can lead to uncontrolled cell growth and cancer.

Effects on Development

During embryonic development, genes provide spatial and temporal instructions guiding cell differentiation and morphogenesis. Mutations in key developmental genes can have profound effects on an organism’s body plan and organ development. For example, mutations in certain homeobox genes can result in missing or duplicated anatomical structures.

Mutations causing a loss of function of growth factor proteins, receptor proteins, or signal transduction proteins can also impair development, leading to dwarfism, skeletal deformations, or neural tube defects like spina bifida or anencephaly. Mutations affecting genes involved in morphogenesis and apoptosis may result in conjoined twins or birth defects like cleft lip/palate as well.

Physiological Effects

Mutations in genes coding for proteins, enzymes, receptors, ion channels, and transporters involved in physiological processes can disrupt homeostasis and normal functioning of the cardiovascular, respiratory, excretory, digestive, endocrine, nervous, immune, musculoskeletal, and reproductive organ systems. For example:

  • Mutations affecting hemoglobin structure can alter oxygen binding and transport, causing sickle cell disease or thalassemia.
  • Mutations in muscle proteins like dystrophin lead to muscular dystrophies.
  • Mutations in hormone receptors like the androgen or estrogen receptors can impair endocrine system signaling and function.
  • Mutations affecting digestive enzymes can prevent proper food breakdown, causing nutritional deficiencies.
  • Mutations in genes for neurotransmitter receptors, ion channels, or structural proteins alter neural signaling and lead to epilepsy, intellectual disability, or psychiatric disorders like depression or schizophrenia.

Effects on Physical Appearance

Mutations can also change physical appearance by altering skin, hair, and eye coloration, limb development, and overall size and proportions. For example:

  • Mutations in the MC1R gene lead to red hair color.
  • Mutations in collagen proteins lead to connective tissue disorders like dwarfism or Marfan syndrome.
  • Mutations in the FGFR3 gene cause achondroplasia, the most common form of dwarfism.
  • Mutations in pigmentation genes like ASIP and TYR lead to albino coloration.
  • Mutations in homeotic genes that control body segmentation can cause extra or missing digits on hands and feet.

Effects on Lifespan

Mutations that impair cellular processes, physiological function, and homeostasis often reduce lifespan by making an organism more susceptible to disease and organ deterioration. Examples include:

  • DNA repair gene mutations leading to accelerated aging disorders like Werner syndrome.
  • Mutations in APP, PSEN1, and PSEN2 genes increasing Alzheimer’s disease risk.
  • Mutations in tumor suppressor genes and oncogenes elevating cancer risk.
  • Mitochondrial DNA mutations impairing cellular energetics.
  • Mutations in cholesterol metabolism genes elevating atherosclerosis and heart disease risk.

However, some mutations can increase lifespan by boosting repair processes or cellular stress resistance. These include mutations activating sirtuin genes or FOXO transcription factors involved in repair and antioxidant pathways.

Population Genetic Effects

At the population level, mutations provide the genetic variation that allows species to adapt and evolve in response to environmental changes and survival pressures. Beneficial mutations become more frequent in populations through natural selection. Harmful mutations tend to be removed through purifying selection. Examples of population genetic effects from mutations include:

  • Spread of malaria resistance mutations like sickle cell trait in tropical regions.
  • Increased frequency of lactose tolerance mutations in pastoral societies reliant on dairy.
  • Fixation of skin pigmentation gene mutations as humans migrated to higher latitudes.
  • Higher incidence of inbreeding depression and deleterious recessive mutations in small isolated populations.

Cancer Development

Mutations that activate oncogenes or inactivate tumor suppressor genes are a key step in cancer pathogenesis. Oncogene mutations cause excessive cell proliferation and survival, while loss of tumor suppressors disables cellular checkpoints and apoptotic pathways that normally remove damaged cells. Key mutation events in cancer include:

  • Point mutations in RAS, MYC, and growth factor genes that lock on proliferation signals.
  • Inactivating mutations in p53, RB, and PTEN tumor suppressor genes disabling apoptosis and cell cycle control.
  • Chromosomal translocations producing fusion genes like BCR-ABL in chronic myelogenous leukemia.
  • Amplifications of growth-promoting genes like HER2/neu in breast cancer.
  • Deletions of DNA repair genes like BRCA1/2 increasing genomic instability.

As mutations accumulate in a cell lineage, they drive cancer progression towards more aggressive and metastatic phenotypes. Mutations also facilitate development of drug resistance by activating alternate survival pathways or altering drug targets.

Germline Mutations and Heritable Diseases

Mutations arising in gametes or during early embryonic development become part of the germline and can be passed onto offspring. These germline mutations increase risk for heritable conditions like:

  • Neurofibromatosis from NF1 mutations.
  • Marfan syndrome from fibrillin gene mutations.
  • Huntington’s disease from trinucleotide repeat expansions in HTT.
  • Cystic fibrosis from mutations in the CFTR chloride channel.
  • Sickle cell anemia from a point mutation in hemoglobin’s beta subunit.

Such inherited mutations cause disease by impacting embryogenesis and physiological processes in every cell of the body. Advanced genetic screening can now detect carriers of these mutations prior to family planning.

Somatic Mutations and Mosaicism

Somatic mutations arise later during development in specific tissues and are not heritable. These can lead to mosaicism – the presence of genetically distinct cell populations within one individual. Somatic mutations cause diseases like:

  • Skin mosaicism from MC1R mutations leading to segmental patches of different pigmentation.
  • Skeletal mosaicism from FGFR3 mutations causing patchy segments ofachondroplasia dwarfism.
  • McCune-Albright syndrome from post-zygotic activating mutations in Gsα.
  • Some forms of neurofibromatosis and tuberous sclerosis from somatic second hit mutations.

Somatic mutations in tumor suppressors like TP53 also initiate many sporadic cancers. Overall, somatic mutations have milder effects than germline mutations since only a subset of cells possess the mutation.

Mitochondrial Mutations

Mitochondria have their own small circular genomes encoding genes required for oxidative phosphorylation. Mutations in mitochondrial DNA can impair cellular energetics and cause debilitating disorders like:

  • MELAS syndrome (mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes).
  • Myoclonic epilepsy with ragged red fibers (MERRF).
  • Leber’s hereditary optic neuropathy leading to blindness.
  • Kearns-Sayre syndrome causing eye abnormalities and nerve damage.

Mitochondrial mutations exhibit unique maternal inheritance patterns and can reach high heteroplasmy levels before disease onset due to the multicopy nature of mitochondrial genomes in cells.

Chromosomal Mutations

Changes in chromosome structure and number also constitute mutational events with profound effects on health and viability. These include:

  • Aneuploidies like trisomy 21 causing Down syndrome.
  • Monosomies like Turner syndrome (45, XO).
  • Translocations and inversions altering gene linkage and regulation.
  • Ring chromosomes formed through fusion of q and p arms.
  • Gene amplifications increasing copy number of oncogenes.
  • Massive deletions leading to disorders like DiGeorge syndrome.

Meiotic nondisjunction accounts for most numerical chromosome mutations. Aberrant mitotic recombination causes translocations and aneuploidies in cancers. Repetitive elements also mediate rearrangements via non-allelic homologous recombination.

Noncoding Region Mutations

Mutations can affect noncoding regulatory regions as well as protein-coding sequences. For example:

  • Promoter mutations that increase or decrease gene transcription.
  • Enhancer mutations altering developmental gene expression.
  • Mutations creating new splice sites or eliminating existing ones.
  • Altered microRNA-binding sites that deregulate mRNA stability and translation.
  • Mutations in 5′ and 3′ UTRs that impair translation efficiency.

Deep intronic mutations that create cryptic splice sites or pseudoexons can also lead to genetic disorders, as can repeat expansions in noncoding regions.

Gene Dosage Mutations

Rather than altering gene sequences, mutations can increase or decrease gene copy number. These gene dosage mutations include:

  • Amplifications that increase oncogene copies in cancers.
  • Copy number variations associated with autism, schizophrenia, and epilepsy.
  • Microdeletions and microduplications of dosage-sensitive genes.
  • Expansions of trinucleotide repeats causing Huntington’s disease.

Gene dose changes impact phenotypes by increasing or decreasing expression of affected genes. Dosage mutations often exhibit greater penetrance since one functional gene copy remains intact.

Epigenetic Mutations

Mutations also occur in the epigenome and alter gene regulation without changing DNA sequence. Common epimutations include:

  • DNA methylation changes in promoter CpG islands.
  • Histone acetylation changes altering chromatin accessibility.
  • Disrupted imprinting causing disorders like Prader-Willi and Angelman syndromes.
  • Aberrant microRNA expression and silencing of target genes.

Cancer cells in particular exhibit global epigenetic abnormalities and mutations in genes encoding histone and DNA modifiers. Unlike DNA mutations, epimutations are reversible with drugs targeting the epigenetic machinery.


In summary, mutations in DNA sequences, chromosome structure, gene dosage, and epigenetic marks can have diverse functional consequences depending on the specific genes and cell types affected. While some mutations cause devastating inherited disorders or cancer, others provide the variation underlying evolution and adaptation. Understanding specific disease-causing mutations provides opportunities for molecular therapies, diagnostics, and genetic counseling.

Leave a Comment